Agilent Technologies, Inc. A | NYSE

$134.51 $1.32 | 0.99%

After Hours
$133.93 -$0.58 | -0.43%

Company Overview:

Market Cap: $38.65B
PE Ratio: 30.36
52-Week Range: $124.16 - $155.35
Dividend Yield (FWD): 0.74% ($0.99)

10 Year Performance Metrics:

Total Return (with DRIP): 248.86% (13.31% / yr)
Total Return (no DRIP): 237.46% (12.93% / yr)
Share Price: 221.18%
Dividend Increase: 136.00%
A 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

A Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
A Dividend CAGR:1Y: 5.08%2Y: 4.99%5Y: 6.62%10Y: 9.51%
Share Price
A Price CAGR:1Y: -2.66%2Y: -4.64%5Y: 9.57%10Y: 12.51%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

A Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - A
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - A
14-Day FREE Trial Get Full Access Now!

A Earnings, Revenue, Cash & Debt, Shares Outstaning:

A - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
A - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
A - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
A - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
A - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
A - Cash & Debt
14-Day FREE Trial Get Full Access Now!
A - Revenue
14-Day FREE Trial Get Full Access Now!
A Revenue CAGR:1Y: 0.77%2Y: -4.09%5Y: 4.47%10Y: -0.59%
A - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
A EPS CAGR:1Y: -24.69%2Y: -0.41%5Y: 14.50%10Y: 37.64%
A - Net Income
14-Day FREE Trial Get Full Access Now!
A Net Income CAGR:1Y: -26.11%2Y: -2.34%5Y: 12.59%10Y: 36.18%
A - EBITDA
14-Day FREE Trial Get Full Access Now!
A EBITDA CAGR:1Y: -20.78%2Y: -13.95%5Y: 4.46%10Y: 7.23%
A - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
A Free Cash Flow CAGR:1Y: -10.19%2Y: 1.31%5Y: 6.44%10Y: 12.36%
A - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
A Free Cash Flow / Share CAGR:1Y: -8.30%2Y: 3.07%5Y: 8.10%10Y: 14.11%
A - Gross Profit
14-Day FREE Trial Get Full Access Now!
A Gross Profit CAGR:1Y: 0.11%2Y: -4.86%5Y: 4.44%10Y: 0.21%
A - Expenses
14-Day FREE Trial Get Full Access Now!
A Expenses CAGR:1Y: 10.71%2Y: 15.26%5Y: 25.39%10Y: 7.53%
A - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
A Shares Outstanding CAGR:1Y: -2.05%2Y: -1.86%5Y: -1.72%10Y: -1.62%
A - Share Buybacks
14-Day FREE Trial Get Full Access Now!
A Share Buybacks CAGR:1Y: 322.50%2Y: 58.23%5Y: 47.14%10Y: 5.39%
A - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
A Stock-Based Comp CAGR:1Y: 78.57%2Y: -1.94%5Y: 10.76%10Y: 2.78%
A - Dividends
14-Day FREE Trial Get Full Access Now!
A Dividend CAGR:1Y: 5.08%2Y: 4.99%5Y: 6.62%10Y: 9.51%
A - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
A Revenue CAGR:1Y: 0.77%2Y: -4.09%5Y: 4.47%10Y: -0.59%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

A - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
A Actual Revenue CAGR:1Y: 0.77%2Y: -4.09%5Y: 4.47%10Y: -0.59%
A - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
A Actual EPS CAGR:1Y: -24.69%2Y: -0.41%5Y: 14.50%10Y: 37.64%
A - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
A Actual Net Income CAGR:1Y: -26.11%2Y: -2.34%5Y: 12.59%10Y: 36.18%
A - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
A Actual EBITDA CAGR:1Y: -20.78%2Y: -13.95%5Y: 4.46%10Y: 7.23%

Ratios, Profit Margins & Return on Capital:

A - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
A Net Profit Margin CAGR:1Y: -26.69%2Y: 1.82%5Y: 7.77%10Y: 36.93%
A - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
A Gross Profit Margin CAGR:1Y: -0.66%2Y: -0.81%5Y: -0.02%10Y: 0.81%
A - Price to Earnings
14-Day FREE Trial Get Full Access Now!
A - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
A - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
A - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

A Dividends Info:

Annual Dividend: $0.99
Forward Yield: 0.74%
Ex-Dividend Date: 2024-12-31
Lifetime Dividens / Share: $9.46

A Dividend History: Dates, Payments & Yield list

Below is a schedule of all A dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
12/31/202401/22/2025$0.2480.71%0.74%$134.51
10/01/202410/23/2024$0.2360.64%0.64%$146.56
07/02/202407/24/2024$0.2360.74%0.75%$125.78
04/01/202404/24/2024$0.2360.63%0.65%$145.56
12/29/202301/24/2024$0.2360.66%0.68%$139.03
10/02/202310/25/2023$0.2250.81%0.81%$110.90
06/30/202307/26/2023$0.2250.74%0.75%$120.25
04/03/202304/26/2023$0.2250.63%0.65%$137.86
12/30/202201/25/2023$0.2250.57%0.6%$149.65
10/03/202210/26/2022$0.2100.66%0.66%$126.38
07/01/202207/27/2022$0.2100.69%0.7%$119.21
04/04/202204/27/2022$0.2100.6%0.62%$134.81
01/03/202201/26/2022$0.2100.51%0.54%$156.48
10/04/202110/27/2021$0.1940.51%0.51%$152.36
07/02/202107/28/2021$0.1940.51%0.52%$148.82
04/05/202104/28/2021$0.1940.58%0.6%$130.00
01/04/202101/27/2021$0.1940.62%0.65%$118.64
10/05/202010/28/2020$0.1800.7%0.7%$103.12
06/29/202007/22/2020$0.1800.81%0.82%$87.29
03/30/202004/22/2020$0.1800.95%0.99%$72.67
12/30/201901/22/2020$0.1800.79%0.85%$84.90
09/30/201910/23/2019$0.1640.86%0.86%$76.63
07/01/201907/24/2019$0.1640.85%0.87%$75.78
04/01/201904/24/2019$0.1640.77%0.8%$81.56
12/28/201801/23/2019$0.1640.93%0.99%$65.96
10/01/201810/24/2018$0.1490.84%0.84%$71.26
07/02/201807/25/2018$0.1490.94%0.97%$61.47
04/02/201804/25/2018$0.1490.87%0.93%$64.43
12/29/201701/24/2018$0.1490.81%0.89%$66.97
10/02/201710/25/2017$0.1320.81%0.81%$64.87
06/29/201707/26/2017$0.1320.87%0.9%$58.80
03/31/201704/26/2017$0.1320.93%1%$52.87
12/29/201601/25/2017$0.1321.05%1.16%$45.64
09/30/201610/26/2016$0.1150.98%0.98%$47.09
06/30/201607/27/2016$0.1151%1.04%$44.36
04/01/201604/27/2016$0.1151.07%1.14%$40.31
12/31/201501/27/2016$0.1150.99%1.1%$41.81
09/25/201510/21/2015$0.1001.16%1.16%$34.45
06/26/201507/22/2015$0.1000.99%1%$40.02
03/27/201504/22/2015$0.1000.95%0.97%$41.11
01/02/201501/28/2015$0.1000.94%0.99%$40.56
09/26/201410/22/2014$0.0940.93%0.93%$40.41
06/27/201407/23/2014$0.0940.9%0.92%$41.13
04/09/201404/23/2014$0.0940.91%0.95%$39.75
12/27/201301/22/2014$0.0940.86%0.92%$40.89
09/27/201310/23/2013$0.0860.89%0.93%$36.93
06/28/201307/24/2013$0.0861.03%1.12%$30.59
03/28/201304/24/2013$0.0861%1.14%$30.02
12/27/201201/23/2013$0.0720.98%0.98%$29.07
09/28/201210/24/2012$0.0720.78%1.04%$27.50
06/29/201207/25/2012$0.0720.51%1.02%$28.07
03/30/201204/25/2012$0.0720.22%0.9%$31.84
11/01/200611/03/2006$1.4716.04%24.14%$24.38

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for A

Based on past 10-year performance, here are A growth metrics:

Share price CAGR of +12.38%
Dividend CAGR of +9.51%
Using A CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

A
Current Price$134.51
Start Shares74.34
Start Value$10,000
 
After 10 years:
Final Share Count79.15
Dividends Payment$0.59
Annual Dividends$185
Yield on cost1.85%
Share Price$384.44
Total Dividends$1,133
Final Value$30,427

Estimated Future Value + Dividends - A

NOTE: Above numbers are our estimate based on A's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Agilent Technologies, Inc. (A) had its IPO on 1999-11-18, and is trader on NYSE stock exchange.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A website: https://www.agilent.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial